- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Ediscovery
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Litigation Support Services
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Disputes
-
March 1, 2021Amy Churan Named an Insurance Trailblazer by National Law Journal
-
March 1, 2021Firm, Partner Recognized by Managing IP
-
3/1/2021Robins Kaplan Recognized in 2021 World Trademark Review 1000
-
March 6, 2021With Our Voices 2021 Arc Gala
-
March 6, 20211st Annual Tee It Up for the Troops Winter Outing
-
March, 9, 2021The New Frontier of Software License Disputes
-
Winter 2021Pro Bono Publico–For The Public Good
-
Winter 2021The Case for Charitable Giving
-
Winter 2021The Fictional Wealth Disputes That We Took In and Learned From in 2020
-
March 3, 2021Financial Daily Dose 3.3.2021 | Top Story: Rare Merck-J&J Partnership to Boost U.S. Vaccine Production
-
March 2, 2021Financial Daily Dose 3.2.2021 | Top Story: U.S. Markets Bounce Back as Bonds Settle
-
March 1, 2021Financial Daily Dose 3.1.2021 | Top Story: Walmart Poaches Goldman Bankers in Bid to Bolster Fintech Venture
Find additional firm contact information for press inquiries.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Key Decisions Affecting Drug and Device Litigation in the Last Year
American Bar Association
February 26, 2021
Remote
Related Professionals
Rayna E. Kessler
Partner
Start time: February 26, 2021 | 11:30 a.m. ET
Duration: 60 minutes
On Friday, February 26, 2021, Rayna Kessler co-presented in a webinar hosted by American Bar Association titled “Key Decisions Affecting Drug and Device Litigation in the Last Year.” The last 12 months have seen a number of cases with significant implications to pharmaceutical and medical device litigation in areas such as personal jurisdiction, preemption, and much more. This session will provide an overview of these and other key decisions impacting the drug and device landscape.
Rayna Kessler - American Bar Association
Learn More
Related Publications
Fall 2020
COVID Immunity: No, Not That Kind of Immunity
Holly Dolejsi - The Robins Kaplan Justice Report
Fall 2020
Rewriting the Odds to Advance Access to Justice
Jason DePauw, Seth Zawila - The Robins Kaplan Justice Report
July 22, 2020
Injectafer Linked to Severe Hypophosphatemia
Kate Jaycox
April 2, 2020
Remote Depositions in the Era of COVID-19
Ian Millican
March 26, 2020
How Policy Makers Can Support the Public’s Access to Justice During COVID-19 – Toll the Deadlines to File New Claims
Rayna Kessler and Adam Mendel
Related News
January 28, 2021
September 17, 2020
September 3, 2020
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.